Japan, U.S. Negotiators Compromise On Length Of Patent Protections
This article was originally published in PharmAsia News
Executive Summary
Japan and U.S. trade officials reached a compromise over the length of protection for drug-research, differentiating between the types of drugs in determining how long to protect trial data.